Acasti pharma to participate at the h.c. wainwright 24th annual global investment conference

Laval, quÉbec, sept. 12, 2022 (globe newswire) -- acasti pharma inc. (“acasti” or the “company”) (nasdaq: acst and tsx-v: acst), a late-stage, specialty pharma company with drug delivery capability and technologies addressing rare and orphan diseases, today announced that management will virtually participate at the h.c. wainwright 24th annual global investment conference september 12-16, 2022.
ACST Ratings Summary
ACST Quant Ranking